Abstract
Gonorrhea is a common cause of bacterial sexually transmitted infection (STI), and in many countries (such as the United Kingdom), it is second only to chlamydial infection (1). In many industrialized countries, the epidemiology of gonorrhea has changed in the last 15–20 yr. After the advent of acquired immunodeficiency syndrome (AIDS) in 1984, there was a rapid decline in the number of cases of STIs, including gonorrhea, reaching a trough in 1990–1991. This decline was followed initially by small increases in the number of cases, which has been sustained with significant increases in STIs in the last 5 yr (1).
Keywords
- Sexually Transmitted Infection
- Antimicrob Agent
- Neisseria Gonorrhoeae
- Western Pacific Region
- Eikenella Corrodens
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
PHLS, DHSS and PS and the Scottish ISD(D)5 Collaborative Group. Sexually Transmitted Infections in the UK: New Episodes Seen at Genitourinary Medicine Clinics, 1991-2001. London: Public Health Laboratory Service, 2002.
Fitzgerald M, Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS 1996; 7: 298 - 300.
Handsfield HH, McCutchan JA, Corey L, Ronald AR. Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15 (suppl. 1): S123 - S130.
Centers for Disease Control. CDC Sexually Transmitted Diseases Guidelines 2002Gonococcal Infections. 2002. Available at: http://www.cdc.gov/std/treatment/42002TG.htm#Gonococcal. Accessed September 9, 2003.
World Health Organization. WHO Guidelines for the Management of Gonococcal Infections. 2001. Available at: http://www.who.int/STIManagemntguidelines/who_hiv_aids_ 2001.01/003.htm#3.1. Accessed September 9, 2003.
Bignell C. 2001 National Guideline for the Management of Gonorrhoea in Adults. Clinical Effectiveness Group of MSSVD/AGUM. 2001. Available at: http://www.mssvd.org.uk/ PDF/CEG2001/gc%200601.PDF. Accessed September 9, 2003.
Goodfellow A, Standley T, Ross JD. Predicting penicillin resistance in patients with gonorrhoea. Sex Transm Infect 1999; 75: 190.
Morse SA, Lysko PG, McFarland L, et al. Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun 1982; 37: 432 - 438.
Tapsall J. Antimicrobial Resistance to Neisseria gonorrhoeae. Geneva, Switzerland: World Health Organization, 2001. WHO/CDS/CSR/DRS/2001.3.
Kraus SJ. Incidence and therapy of gonococcal pharyngitis. Sex Transm Dis 1979; 6: 143 - 147.
Ropp PA, Hu M, Olesky M, Nicholas RA. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance. Antimicrob Agents Chemother 2002; 46: 769 - 777.
Faruki H, Kohmescher RN, McKinney WP, Sparling PF. A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med 1985; 313: 607 - 611.
Ashford WA, Golash RG, Hemming VG. Penicillinase-producing Neisseria gonorrhoeae. Lancet 1976; 2: 657 - 658.
Percival A, Rowlands J, Corkhill JE, et al. Penicillinase-producing gonococci in Liverpool. Lancet 1976; 2: 1379 - 1382.
Spratt BG. Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae. Nature 1988; 332: 173 - 176.
Brannigan, JA, Tirodimos IA, Zhang QY, Dowson CG, Spratt BG. Insertion of an extra aminoacid is the main cause of the low affinity of penicillin-binding protein 2 in penicillin resistant strains of Neisseria gonorrhoeae. Mol Microbiol 1990; 4: 913 - 919.
Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 1995; 141: 611 - 622.
Delahay RM, Robertson BD, Balthazar JT, Shafer WM, Ison CA. Involvement of the gonococcal MtrE protein in the resistance of Neisseria gonorrhoeae to toxic hydrophobic agents. Microbiology 1997; 143: 2127 - 2133.
Sparling PF, Sarubbi FA Jr, Blackman E. Inheritance of low-level resistance to penicillin, tetracycline and chloramphenicol in Neisseria gonorrhoeae. J Bacteriol 1975; 124: 740 - 749.
Gill MJ, Simjee S, Al-Hattawi K, Robertson BD, Easmon CSF, Ison CA. Gonococcal resistance to 13-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob Agents Chemother 1998; 42: 2799 - 2803.
Ropp PA, Nicholas RA. Cloning and characterization of the ponA gene encoding penicillin-binding protein 1 from Neisseria gonorrhoeae and Neisseria meningitidis. J Bacteriol 1997; 179: 2783 - 2787.
Roberts M, Elwell LP, Falkow S. Molecular characterization of two (3-lactamase-specifying plasmids isolated from Neisseria gonorrhoeae. J Bacteriol 1977; 131: 557 - 563.
Roberts MC. Plasmids of Neisseria gonorrhoeae and other Neisseria species. Clin Microbiol Rev 1989; 2 (suppl.): S18 - S23.
Pagotto F, Aman AT, Ng LK, Teung KH, Brett M, Dillon JA. Sequence analysis of the family of penicillinase-producing plasmids of Neisseria gonorrhoeae. Plasmid 2000; 43: 24 - 34.
WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Pacific Region, 2000. Commun Dis Intell 2001; 25: 274 - 277.
Bignell CJ. European guideline for the management of gonorrhoea. Int J STD AIDS 2001; 12 (suppl. 3): 27 - 29.
Schwebke JR, Whittington W, Rice RJ, Handsfield HH, Hale J, Holmes KK. Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991. Antimicrob Agents Chemother 1995; 39: 917 - 920.
Ison CA, Bindayna KM, Woodford N, Gill MJ, Easmon CSF. Penicillin and cephalosporin resistance in gonococci. Genitourin Med 1990; 66: 351 - 356.
Galimand M, Gerbaud G, Courvalin P. Spectinomycin resistance in Neisseria spp due to mutations in 16S rRNA. Antimicrob Agents Chemother 2000; 44: 1365 - 1366.
Boslego JW, Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 1987; 317: 272 - 278.
Spectinomycin-resistant penicillinase producing Neisseria gonorrhoeae -California. MMWR Morb Mortal Wkly Rep 1981; 30:221-222.
Zenilman JM, Nims LJ, Menegus MA, Nolte F, Knapp JS. Spectinomycin-resistant gonococcal infections in the United States, 1985-86. J Infect Dis 1987; 156: 1002 - 1004.
Easmon CSF, Ison CA, Bellinger CM, Harris JRW. Emergence of resistance after spectinomycin treatment for gonorrhoea due to (3-lactamase-producing strain of Neisseria gonorrhoeae. BMJ 1982; 284: 1604 - 1605.
Drlica K, Zhao X. DNA gyrase, topisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997; 61: 377 - 392.
Belland RJ, Morrison SG, Ison C, Huang WM. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 1994; 14: 371 - 380.
Trees DL, Sandul AL, Whittington WL, Knapp JS. Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1998; 42: 2103 - 2105.
Trees DL, Sandul AL, Neal SW, Higa H, Knapp JS. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii, 1991-1999. Sex Transm Dis 2001; 28: 309 - 314.
Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis 1997; 3: 33 - 38.
Shultz TR, Tapsall JW, White PA. Correlation of in vitro susceptibilities to newer quinolones of naturally-occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC. Antimicrob Agents Chemother 2001; 45: 734 - 738.
Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797 - 799.
Young H, Moyes A, McMillan A. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int J STD AIDS 1997; 8: 299 - 302.
Zaratonnelli L, Borthagaray G, Lee E-H, Shafer WM. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother 1999; 43: 2468 - 2472.
Xia M, Whittington WL, Shafer WM, Holmes KK. Gonorrhoea among men who have sex with men: an outbreak caused by a single genotype of erythromycin-resistant Neisseria gonorrhoeae with a single-base pair deletion in the mtrR promotor region. J Infect Dis 2000; 181: 2080 - 2082.
Shafer WM, Veal WL, Lee EH, Zarantonelli L, Balthazar JT, Roquette C. Genetic organization and regulation of antimicrobial efflux system possessed by Neisseria gonorrhoeae and Neisseria meningitidis. J Mol Microbiol Biotechnol 2001; 3: 219 - 224.
Luna VA, Cousin S Jr, Whittington WL, Roberts MC. Identification of the conjugative mef genes in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother 2000; 44: 2503 - 2506.
Roberts MC, Chung WO, Roe D, et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 1999; 43: 1367 - 1372.
Ng L-K, Martin I, Liu G, Bryden L. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 3020 - 3025.
Johnson SR, Morse SA. Antibiotic resistance in Neisseria gonorrhoeae, genetics and mechanisms of resistance. Sex Transm Dis 1988; 15: 217 - 224.
Morse SA, Johnson SR, Biddle JW, Roberts MC. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 1986; 30: 664 - 670.
Knapp JS, Johnson SR, Zenilman JM, Roberts MC, Morse SA. High-level tetracycline resistance resulting from TetM in strains of Neisseria spp, Kingella denitrificans, and Eikenella corrodens. Antimicrob Agents Chemother 1988; 32: 765 - 767.
Daly CC, Hoffman I, Hobbs M, et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi. J Clin Microbiol 1997; 35: 2985 - 2988.
Lkhamsuren E, Shultz TR, Limnios EA, Tapsall JW. The antibiotic susceptibility of Neisseria gonorrhoeae isolated in Ulaanbaatar, Mongolia. Sex Transm Infect 2001; 77: 218 - 219.
West B, Changalucha J, Grooskurth H, et al. Antimicrobial susceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in northern Tanzania: emergence of high-level plasmid mediated tetracycline resistance. Genitourin Med 1995; 71: 9 - 12.
OCallaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of ßlactamases by using chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283 - 288.
Livermore DM, Brown DFJ. Detection of ß-lactamase-mediated resistance. J Antimicrob Chemother 2001; 48 (suppl. S1): 59 - 64.
World Health Organization. Bench-Level Manual for Sexually Transmitted Diseases. Geneva, Switzerland: World Health Organization. WHO/VDT/89. 1989, p. 443.
National Committee for Clinical Laboratory Standards. Approved Standard: Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. Villanova, PA: National Committee for Clinical Laboratory Standards. 2003 Document M2-A8.
King A. Recommendations for susceptibility tests on fastidious organisms and those requiring special handling. J Antimicrob Chemother 2001; 48 (suppl.): 77 - 80.
Ison CA, Martin DM. Gonorrhoea. In: Morse SA, Ballard R (eds.). Atlas of Sexually Transmitted Diseases. London: Harcourt Health Sciences, 2002, pp. 109 - 125.
Ison CA, Branley NS, Kirtland K, Easmon CSF. Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae. BMJ 1991; 303: 1307.
Members of the Australian Gonococcal Surveillance Programme. Penicillin sensitivity of gonococci in Australia: development of Australian gonococcal surveillance programme. Br J Vener Dis 1984; 60: 226 - 230.
Ison CA, Martin IMC, London Gonococcal Working Group. Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. Sex Transm Infect 1999; 75: 107 - 111.
Palmer HM, Leeming JP, Turner A. A multiplex polymerase chain reaction to differentiate 13-lactamase plasmids of Neisseria gonorrhoeae. J Antimicrob Chemother 2000; 45: 777 - 782.
Xia M, Pang Y, Roberts MC. Detection of two groups of 25.2 MDa Tet M plasmids by polymerase chain reaction of the downstream region. Mol Cell Probes 1995; 9: 327 - 332.
Ison CA, Tekki N, Gill MJ. Detection of the tetM determinant in Neisseria gonorrhoeae. Sex Transm Dis 1993; 20: 329 - 333.
Deguchi T, Yasuda M, Nakano M, et al. Rapid screening of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J Clin Microbiol 1996; 34: 2255 - 2258.
Deguchi T, Yasuda M, Nakano M, et al. Rapid screening of point mutations of Neisseria gonorrhoeae parC associated with resistance to the quinolones. J Clin Microbiol 1997; 35: 948 - 950.
Ng L-K, Sawatzky P, Martin IE, Booth S. Characterisation of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada. Sex Transm Dis 2002; 29: 780 - 788.
Rahman M, Alam A, Nessa K, et al. Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh. Clin Infect Dis 2001; 32: 884 - 889.
Ng PP, Chan RK, Ling AE. Gonorrhoea treatment failure and ciprofloxacin resistance. Int J STD AIDS 1998; 9: 323 - 325.
OMahony C, Timmins D. Treatment failure using double dose ciprofloxacin in a case of highly resistant gonorrhoea. Genitourin Med 1992; 68: 274 - 275.
Ison CA, Dillon JR, Tapsall J. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998; 351 (suppl.): 8 - 11.
Schwarcz SK, Zenilman JM, Schnell D, et al. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. JAMA 1990; 264: 1413 - 1417.
Dillon JR. National microbiological surveillance of the susceptibility of gonococcal isolates to antimicrobial agents. Can J Infect Dis 1992; 3: 202 - 206.
Australian Gonococcal Surveillance Program. Penicillin sensitivity of gonococci in Australia: development of Australian gonococcal surveillance program. Genitourin Med 1988; 61: 147 - 151.
Van de Laar MJW, van Duynhoven YTPH, Dessens M, van Santen M, van Klingeren B. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the Netherlands, 199795. Genitourin Med 1997; 73: 510 - 517.
World Health Organization. Global Surveillance Network for Gonococcal Antimicrobial Susceptibility. Geneva, Switzerland: World Health Organization. WHO/VDT/90-452.
Mayaud P, West B, Lloyd-Evans N, Seck K. GASP-WAR: West African network to tackle gonorrhoea. Lancet 2002; 359: 173.
GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2000 Report. London: Public Health Laboratory Service, 2001.
GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2001 Report. London: Public Health Laboratory Service, 2002.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ison, C.A., Ross, J. (2004). The Management of Antibiotic-Resistant Neisseria gonorrhoeae . In: Gillespie, S.H. (eds) Management of Multiple Drug-Resistant Infections. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-738-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-738-3_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-438-8
Online ISBN: 978-1-59259-738-3
eBook Packages: Springer Book Archive